Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
Mumbai: Tata Sons-backed biotech startup MedTherapy has claimed a major breakthrough in CAR-T cell therapy manufacturing, saying its next-generation platform can reduce production timelines from several weeks to just ...
